Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAALV29042
Magnesium Glycinate Bisglycinate + Vitamine B6 Haute dose 1422 mg, 180 Gélules- Origine Angleterre UK
hero
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
13
▼ 80.0% vs prev 4w
Offer Stock
4
Σ Stock across 2 live offers (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 273
avg of last 30 sells · latest 2026-09-16
AAALV29042
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 257 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisglycinate + Vitamine B6 Haute dose 1422 mg, 180 Gélules- Origine Angleterre UK · in the hero cohort · last 4 weeks 13 units, trending down -80.0% · on-hand 17 units
Signals the model saw
- Cohort: hero (672 days of history, 484 units sold over 52 weeks)
- Volatility (CV): 0.72 — moderate
- Recent trend: last 4w = 13 units · prev 4w = 65 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 2.0 units |
| Realistic forecast — next 4 weeks | 7.3 units |
| Realistic forecast — next 3 months | 55.8 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 20.4 units |
| Optimistic — next week | 15.7 units |
| Optimistic — next 4 weeks (reorder target) | 89.2 units |
| Optimistic — next 3 months (quarterly PO target) | 256.9 units |
| Legacy μ/wk (reorder pipeline) | 9.2 |
| Revenue exposure — optimistic, 3 months | MAD 70.1K |